Cargando…
Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma
We present a case series of four patients with circumscribed choroidal hemangioma (CCH) treated with half-dose PDT, proposing this as a novel treatment protocol. Four patients with CCH were included, and then evaluated using multimodal imaging, including optical coherence tomography (OCT), fluoresce...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696376/ https://www.ncbi.nlm.nih.gov/pubmed/36362903 http://dx.doi.org/10.3390/life12111748 |
_version_ | 1784838302093803520 |
---|---|
author | Pérez-González, David Goldstein, Michaella Iglicki, Matias Zur, Dinah |
author_facet | Pérez-González, David Goldstein, Michaella Iglicki, Matias Zur, Dinah |
author_sort | Pérez-González, David |
collection | PubMed |
description | We present a case series of four patients with circumscribed choroidal hemangioma (CCH) treated with half-dose PDT, proposing this as a novel treatment protocol. Four patients with CCH were included, and then evaluated using multimodal imaging, including optical coherence tomography (OCT), fluorescein angiography, indocyanine green angiography, fundus autofluorescence, and ultrasound following treatment with half-dose and full-fluence PDT. Following half-dose PDT, all patients showed significant shrinkage of the hemangioma, functional improvement, and decrease of intra- and sub-retinal fluid. All patients remained stable after a single PDT treatment, with a follow-up of up to 60 months. No side effects were shown. This is the first report showing long term efficacy of half-dose PDT treatment in cases with CCH. The outcomes from this pilot study are comparable with results using full dose PDT protocols and it can be considered as a viable treatment option for CCH during the ongoing global verteporfin shortage. |
format | Online Article Text |
id | pubmed-9696376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96963762022-11-26 Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma Pérez-González, David Goldstein, Michaella Iglicki, Matias Zur, Dinah Life (Basel) Article We present a case series of four patients with circumscribed choroidal hemangioma (CCH) treated with half-dose PDT, proposing this as a novel treatment protocol. Four patients with CCH were included, and then evaluated using multimodal imaging, including optical coherence tomography (OCT), fluorescein angiography, indocyanine green angiography, fundus autofluorescence, and ultrasound following treatment with half-dose and full-fluence PDT. Following half-dose PDT, all patients showed significant shrinkage of the hemangioma, functional improvement, and decrease of intra- and sub-retinal fluid. All patients remained stable after a single PDT treatment, with a follow-up of up to 60 months. No side effects were shown. This is the first report showing long term efficacy of half-dose PDT treatment in cases with CCH. The outcomes from this pilot study are comparable with results using full dose PDT protocols and it can be considered as a viable treatment option for CCH during the ongoing global verteporfin shortage. MDPI 2022-10-31 /pmc/articles/PMC9696376/ /pubmed/36362903 http://dx.doi.org/10.3390/life12111748 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pérez-González, David Goldstein, Michaella Iglicki, Matias Zur, Dinah Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma |
title | Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma |
title_full | Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma |
title_fullStr | Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma |
title_full_unstemmed | Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma |
title_short | Half-Dose Photodynamic Therapy as a Novel Treatment Protocol for Circumscribed Choroidal Hemangioma |
title_sort | half-dose photodynamic therapy as a novel treatment protocol for circumscribed choroidal hemangioma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696376/ https://www.ncbi.nlm.nih.gov/pubmed/36362903 http://dx.doi.org/10.3390/life12111748 |
work_keys_str_mv | AT perezgonzalezdavid halfdosephotodynamictherapyasanoveltreatmentprotocolforcircumscribedchoroidalhemangioma AT goldsteinmichaella halfdosephotodynamictherapyasanoveltreatmentprotocolforcircumscribedchoroidalhemangioma AT iglickimatias halfdosephotodynamictherapyasanoveltreatmentprotocolforcircumscribedchoroidalhemangioma AT zurdinah halfdosephotodynamictherapyasanoveltreatmentprotocolforcircumscribedchoroidalhemangioma |